Challenges in the treatment of BRAF K601E-mutated lung carcinoma: a case report of rapid response and resistance to dabrafenib and trametinib.

MLA

Akihiro Nishiyama, et al. “Challenges in the Treatment of BRAF K601E-Mutated Lung Carcinoma: A Case Report of Rapid Response and Resistance to Dabrafenib and Trametinib.” Frontiers in Oncology, July 2024, pp. 01–05. EBSCOhost, https://doi.org/10.3389/fonc.2024.1374594.

APA

Akihiro Nishiyama, Shigeki Sato, Hiroyuki Sakaguchi, Hiroshi Kotani, Kaname Yamashita, Koushiro Ohtsubo, Shigeki Nanjo, Seiji Yano, Keishi Mizuguchi, Hiroko Ikeda, & Shinji Takeuchi. (2024). Challenges in the treatment of BRAF K601E-mutated lung carcinoma: a case report of rapid response and resistance to dabrafenib and trametinib. Frontiers in Oncology, 01–05. https://doi.org/10.3389/fonc.2024.1374594

Chicago

Akihiro Nishiyama, Shigeki Sato, Hiroyuki Sakaguchi, Hiroshi Kotani, Kaname Yamashita, Koushiro Ohtsubo, Shigeki Nanjo, et al. 2024. “Challenges in the Treatment of BRAF K601E-Mutated Lung Carcinoma: A Case Report of Rapid Response and Resistance to Dabrafenib and Trametinib.” Frontiers in Oncology, July, 01–05. doi:10.3389/fonc.2024.1374594.